Anglo Scientific has built a carefully selected stable of companies with strong growth prospects and the potential of considerable upside for investors. AS Principals have invested significant personal sums across the portfolio as testament to this belief.
Invest Directly
AS companies fundraise throughout the year and sophisticated investors may prefer the opportunity to invest into one or more companies directly at the next fundraising round. For more information including details of these rounds, please contact the companies directly via their websites or alternatively email Will Addison at the address below, who will put you in touch with the appropriate company director.
Email will@angloscientific.com.
EIS Fund
Innvotec (an experienced FSA regulated venture capital fund manager) manages the annual Anglo Scientific EIS fund which combines a compelling investment strategy with a range of tax advantages under the Enterprise Investment Scheme.
By investing in this fund, individuals, trusts and charities can benefit from generous tax advantages including:
- Income tax relief
- Capital Gains Tax relief
- Inheritance tax exemption
For more information on the Anglo Scientific fund please see the Innvotec website: http://www.innvotec.co.uk/.
"Anglo Scientific's expertise in identifying opportunities and building businesses with a real chance of exit offers the investor significant return potential"
John Marsden (fund manager)
For fund enquiries, please email: j.marsden@innvotec.co.uk.
Anglo Scientific is not FSA regulated and any investments made directly into the portfolio companies are done so at the investors own risk. Investments into the Anglo Scientific annual EIS fund must be made through the fund manager, Innvotec.